Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ovid Therapeutics Inc patents


Recent patent applications related to Ovid Therapeutics Inc. Ovid Therapeutics Inc is listed as an Agent/Assignee. Note: Ovid Therapeutics Inc may have other listings under different names/spellings. We're not affiliated with Ovid Therapeutics Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Ovid Therapeutics Inc-related inventors


Methods of treating developmental disorders using pipradrol

Methods of treating developmental disorders by administering a pharmaceutical composition of pipradrol or a pharmaceutically acceptable salt thereof are provided. The methods may be used to treat conditions such as epilepsy, landau-kleffner syndrome, lennox-gastaut syndrome (lgs) and dravet syndrome.. ... Ovid Therapeutics Inc

Methods of treating developmental disorders and/or seizure disorders with flupirtine

Methods of treating developmental disorders and/or seizure disorders with flupirtine or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder and/or seizure disorder.. ... Ovid Therapeutics Inc

Methods of treating developmental disorders with gaboxadol

Methods of treating developmental disorders such as angelman syndrome, fragile x syndrome, fragile x-associated tremor/ataxia syndrome (fxtas), autistic spectrum disorder, autism, asperger's syndrome, pervasive developmental disorder, childhood disintegrative disorder, rett syndrome, lanau-kleffner syndrome, prader-willi syndrome, tardive dyskinesia, and/or williams syndrome with gaboxadol or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder.. ... Ovid Therapeutics Inc

Methods of treating developmental disorders with biguanides

Methods of treating developmental disorders such as angelman syndrome, fragile x syndrome, fragile x-associated tremor/ataxia syndrome (fxtas), autistic spectrum disorder, autism, asperger's syndrome, pervasive developmental disorder, childhood disintegrative disorder, rett syndrome, landau-kleffner syndrome, prader-willi syndrome, tardive dyskinesia, a seizure disorder and/or williams syndrome with a biguanide such as metformin, buformin, phenformin or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder.. ... Ovid Therapeutics Inc

Methods and compositions for treatment of epileptic disorders

Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.. . ... Ovid Therapeutics Inc

Methods of treating behavioral syndromes using pipradrol

Methods of treating behavioral syndromes by administering a pharmaceutical composition of pipradrol or a pharmaceutically acceptable salt thereof are provided. The methods may be used to treat attention-deficit disorder (add) and attention-deficit hyperactivity disorder (adhd).. ... Ovid Therapeutics Inc

Methods of increasing tonic inhibition and treating secondary insomnia

Methods of increasing tonic inhibition in a subject in need thereof, for example a subject with fragile x syndrome or angelman syndrome are disclosed. Methods of treating secondary insomnia in a subject with a neurodegenerative disease or disorder are also disclosed. ... Ovid Therapeutics Inc

Formulations of gaboxadol for treatment of angelman syndrome, fragile x syndrome and fragile x-associated tremor/ataxia syndrome

. . Methods and pharmaceutical compositions for treating angelman syndrome, fragile x syndrome and fragile x-associated tremor/ataxia syndrome with gaboxadol or a pharmaceutically acceptable salt thereof are provided.. . ... Ovid Therapeutics Inc

Methods of treating behavioral syndromes using pipradrol

Methods of treating behavioral syndromes by administering a pharmaceutical composition of pipradrol or a pharmaceutically acceptable salt thereof are provided. The methods may be used to treat attention-deficit disorder (add) and attention-deficit hyperactivity disorder (adhd).. ... Ovid Therapeutics Inc

Methods of treating developmental disorders using gaboxadol

Methods of treating a developmental disorder such as dravet syndrome by administering a pharmaceutical composition of gaboxadol or a pharmaceutically acceptable salt thereof are provided.. . ... Ovid Therapeutics Inc

Methods of increasing tonic inhibition and treating secondary insomnia

Methods of increasing tonic inhibition in a subject in need thereof, for example a subject with fragile x syndrome or angelman syndrome are disclosed. Methods of treating secondary insomnia in a subject with a neurodegenerative disease or disorder are also disclosed. ... Ovid Therapeutics Inc

Methods of treating developmental disorders using gaboxadol

Methods of treating a developmental disorder such as dravet syndrome by administering a pharmaceutical composition of gaboxadol or a pharmaceutically acceptable salt thereof are provided.. . ... Ovid Therapeutics Inc

Methods of treating developmental disorders using pipradrol

Methods of treating developmental disorders by administering a pharmaceutical composition of pipradrol or a pharmaceutically acceptable salt thereof are provided. The methods may be used to treat conditions such as epilepsy, landau-kleffner syndrome, lennox-gastaut syndrome (lgs) and dravet syndrome.. ... Ovid Therapeutics Inc

Treatment of cognitive impairment

Provided are methods of treating cognitive impairment and/or psychosis and/or movement disorders by administering a pharmaceutical composition of eplivanserin or a pharmaceutically acceptable salt thereof to a subject in need thereof.. . ... Ovid Therapeutics Inc

03/30/17 / #20170087133

Methods of increasing tonic inhibition and treating secondary insomnia

Methods of increasing tonic inhibition in a subject in need thereof, for example a subject with fragile x syndrome or angelman syndrome are disclosed. Methods of treating secondary insomnia in a subject with a neurodegenerative disease or disorder are also disclosed. ... Ovid Therapeutics Inc

03/16/17 / #20170071917

Methods of increasing tonic inhibition and treating secondary insomnia

Methods of increasing tonic inhibition in a subject in need thereof, for example a subject with fragile x syndrome or angelman syndrome are disclosed. Methods of treating secondary insomnia in a subject with a neurodegenerative disease or disorder are also disclosed. ... Ovid Therapeutics Inc

03/09/17 / #20170065572

Methods of treating developmental disorders using pipradrol

Methods of treating developmental disorders by administering a pharmaceutical composition of pipradrol or a pharmaceutically acceptable salt thereof are provided. The methods may be used to treat conditions such as epilepsy, landau-kleffner syndrome, lennox-gastaut syndrome (lgs) and dravet syndrome.. ... Ovid Therapeutics Inc

02/16/17 / #20170042863

Methods of sedation during critical care treatment

Methods of sedating a patient undergoing critical care treatment using intravenous gaboxadol are provided.. . ... Ovid Therapeutics Inc

01/19/17 / #20170014393

Methods of treating developmental disorders with gaboxadol

Methods of treating developmental disorders such as angelman syndrome, fragile x syndrome, fragile x-associated tremor/ataxia syndrome (fxtas), autistic spectrum disorder, autism, asperger's syndrome, pervasive developmental disorder, childhood disintegrative disorder, rett syndrome, lanau-kleffner syndrome, prader-willi syndrome, tardive dyskinesia, and/or williams syndrome with gaboxadol or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder.. ... Ovid Therapeutics Inc

01/19/17 / #20170014392

Methods of treating developmental disorders using gaboxadol

Methods of treating a developmental disorder such as dravet syndrome by administering a pharmaceutical composition of gaboxadol or a pharmaceutically acceptable salt thereof are provided.. . ... Ovid Therapeutics Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ovid Therapeutics Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ovid Therapeutics Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###